FindTrial
Sign In

Establishment and validation of prognosis prediction model for patients with stable vitiligo

Establishment and validation of prognosis prediction model for patients with stable vitiligo

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200059978
Enrollment
Unknown
Registered
2022-05-14
Start date
2022-05-01
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

vitiligo

Interventions

Case group:None

Sponsors

Xinjiang Uygur Autonomous Region Uygur Medical Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Fulfilled the criteria of the diagnosis of vitiligo in the 2014 consensus on the diagnosis of vitiligo; 2. Age = 8 years, = 65 years.

Exclusion criteria

Exclusion criteria: 1. Depigmentation, anemia nevus, albinism, pigment-free nevus, solar leukoplakia, etc. left after the skin rash recovers; 2. Patients with various tuberculosis, tumor, AIDS, syphilis, gonorrhea and other infectious diseases; 3. Heart failure, liver and kidney dysfunction; 4. Those who have taken steroids in the past two weeks or retinoic acid and other drugs in one week or who have taken steroids locally; 5. Pregnant and lactating women; 6. Those suspected or having a history of drug abuse; 7. Patients who have participated in other clinical trials in the past month.

Design outcomes

Primary

MeasureTime frame
White spot area;Pigment area;CD4+;CD8+;Treg cell;IL-17;IL-23;TGF-ß;—

Countries

China

Contacts

Public ContactAiniwaer Talifu

Xinjiang Uygur Autonomous Region Uygur Medical Hospital

154914729@qq.com+86 13699965292

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026